TherapeuticsMD, Inc. - FORM 10-K - EX-23.1 - CONSENT OF GRANT THORNTON LLP - March 3, 2021

Attached files

file filename
10-K - ANNUAL REPORT - TherapeuticsMD, Inc.txmd-10k_123120.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex32-2.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.ex32-1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex31-2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.ex31-1.htm
EX-10.42 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH EDWARD J. BORKOWSKI - TherapeuticsMD, Inc.ex10-42.htm
EX-10.41 - EMPLOYMENT AGREEMENT WITH EDWARD J. BORKOWSKI - TherapeuticsMD, Inc.ex10-41.htm
EX-10.25 - AMENDMENT NO. 8 TO THE FINANCING AGREEMENT - TherapeuticsMD, Inc.ex10-25.htm
EX-10.24 - AMENDMENT NO. 7 TO THE FINANCING AGREEMENT - TherapeuticsMD, Inc.ex10-24.htm
EX-10.16 - AMENDMENT TO WARRANT ISSUED TO JOHN C.K. MILLIGAN, IV - TherapeuticsMD, Inc.ex10-16.htm
EX-10.15 - WARRANT ISSUED TO JOHN C.K. MILLIGAN, IV - TherapeuticsMD, Inc.ex10-15.htm
EX-10.14 - AMENDMENT TO WARRANT ISSUED TO ROBERT G. FINIZIO - TherapeuticsMD, Inc.ex10-14.htm
EX-10.13 - WARRANT ISSUED TO ROBERT G. FINIZIO - TherapeuticsMD, Inc.ex10-13.htm
EX-10.12 - SECOND AMENDMENT TO COMPANY WARRANT - TherapeuticsMD, Inc.ex10-12.htm

 

TherapeuticsMD, Inc. 10-K

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 3, 2021, with respect to the consolidated financial statements included in the Annual Report of TherapeuticsMD, Inc. on Form 10-K for the year ended December 31, 2020. We consent to the incorporation by reference of said report in the Registration Statements of TherapeuticsMD, Inc. on Form S-3 (File No. 333-226452) and on Forms S-8 (File No. 333-191730, File No. 333-232268 and File No. 333-242363).

 

/s/ GRANT THORNTON LLP

 

Miami, Florida

March 3, 2021

 

 82

TherapeuticsMD, Inc. Reports